All Work

Jon C. Ogg

Vertex RA Study: When Good Is Not Good Enough (VRTX)

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) might have sounded as though shares would be up Monday morning if you were just looking at news over the weekend.  Instead, shares are down substantially for a day…

Jon C. Ogg · 15 years ago

Sprint’s Note Offering Rescues Clearwire (S, CLWR)

Sprint Nextel Corporation (NYSE: S) is coming to the aid of Clearwire Corporation (NASDAQ: CLWR).  Sprint has been known (or thought of) to be a capital raising entity and this morning we are getting…

Jon C. Ogg · 15 years ago

The Groupon IPO Price Conundrum (GRPN)

This story was updated for live coverage throughout the day…. with 6 updates….    Groupon Inc. (NASDAQ: GRPN) not only made it to the public market, but it managed to come at a premium.  The bulls will say…

Jon C. Ogg · 15 years ago

Medivation, A Pain in the Rear for Dendreon (MDVN, DNDN)

Medivation, Inc. (NASDAQ: MDVN) is today’s darling in biotech and emerging pharmaceuticals.  It and partner Astellas in Japan showed very positive data on its prostate cancer drug candidate. Its shares are up more than…

Jon C. Ogg · 15 years ago

The Endless Unwinding of Eastman Kodak (EK)

Eastman Kodak Co. (NYSE: EK) is doomed.  It has already been rumored in prior weeks that the company was going to restructure.  Now its earnings could make a rumor a self-fulfilling prophecy if repeated…

Jon C. Ogg · 15 years ago

FOMC Lowers Long-Term Growth & Jobs Forecasts

The good news is that the Federal Reserve is not calling for a recession and it still is calling for growth ahead.  While we noted even last week that there were 10 indicators signaling…

Jon C. Ogg · 15 years ago